Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years

Archive ouverte

Blay, JY | Tlemsani, C. | Toulmonde, M. | Italiano, A. | Rios, M. | Bompas, E. | Valentin, T. | Duffaud, F. | Le Nail, Lr | Watson, S. | Firmin, N. | Dubray-Longeras, P. | Ropars, M. | Perrin, C. | Hervieu, A. | Lebbe, C. | Saada-Bouzid, E. | Soibinet, P. | Fiorenza, F. | Bertucci, F. | Boudou, P. | Vaz, G. | Bonvalot, S. | Honoré, C. | Marec-Berard, P. | Minard, V. | Cleirec, M. | Biau, D. | Meeus, P. | Babinet, A. | Dumaine, V. | Carriere, S. | Fau, M. | Decanter, G. | Gouin, F. | Ngo, C. | Le Loarer, F. | Karanian, M. | Meurgey, A. | Dufresne, A. | Brahmi, M. | Chemin-Airiau, C. | Ducimetiere, F. | Penel, N. | Le Cesne, A.

Edité par CCSD ; Elsevier -

International audience. Sclerosing Epithelioid Fibrosarcoma (SEF) and Low Grade Fibromyxoid Sarcoma (LGFMS) are ultrarare sarcomas sharing common translocations whose natural history are not well known. We report on the nationwide exhaustive series of 330 patients with SEF or LGFMS in NETSARC+ since 2010.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion